Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Ovarian Epithelial × Ramucirumab × Clear all

Sponsor

Conditions

Stomach Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Carcinoma, Hepatocellular 6 Adenocarcinoma 6 Neoplasms 5 Colorectal Neoplasms 4 Colonic Neoplasms 4 Breast Neoplasms 4 Urethral Neoplasms 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Liver Neoplasms 3 Carcinoma, Renal Cell 3 Urinary Bladder Neoplasms 2 Ureteral Neoplasms 2 Solid Tumors 2 Sarcoma 2 Non-small Cell Lung Cancer Metastatic 2 Malignant Solid Tumor 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Biliary Tract Neoplasms 2 Thymoma 1 Sarcoma, Synovial 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Metastatic Gastric Adenocarcinoma 1

Interventions

Paclitaxel 21 Carboplatin 16 liposomal doxorubicin 12 Bevacizumab 8 Topotecan 7 Docetaxel 7 Cisplatin 7 pembrolizumab 6 rucaparib 5 mirvetuximab soravtansine 5 Gemcitabine 5 Cyclophosphamide 5 Taxes 4 Albumin-Bound Paclitaxel 4 sargramostim 3 ixabepilone 3 Cytoreduction Surgical Procedures 3 130-nm albumin-bound paclitaxel 3 taxane 2 talazoparib 2 pazopanib 2 fludarabine phosphate 2 fludarabine 2 denileukin diftitox 2 cediranib 2 catumaxomab 2 belinostat 2 avelumab 2 aflibercept 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡